mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |